Azacitidine Prolongs Overall Survival in Older Patients with Acute Myeloid Leukemia (AML) with Poor Prognostic Karyotypes. (April 2017) - Döhner, H.; Vyas, P.; Seymour, J.F.; Santini, V.; Stone, R.M.; Minden, M.D.; Al-Ali, H.K.; del Castillo, T. Bernal; Morrill, J.; Songer, S.; Weaver, J.; Skikne, B.S.; et al.